We help biotech companies efficiently manufacture viral vectors for cell and gene therapy and vaccines through our proprietary technologies, which are available for licensing. Our cutting-edge solutions are designed to simplify and streamline the viral vector manufacturing process, making it more efficient than ever before. With expertise in viral vector design and process development, we specialize in Adeno-associated virus (AAV), Lentivirus, and viral-based vaccines. We are actively seeking partners to evaluate and collaborate on our innovative technologies. If you're interested, please contact us.
VVECTOR BIO, Bridging Research and Clinic
2020 VVECTOR BIO. All Rights Reserved